Norway
# |
Name |
Return on Capital Employed (ROCE) |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
31.95%
|
Dec. 31, 2023 | USD 13.86 | -1.83% |
|
Norway |
|
2 |
7.95%
|
Dec. 31, 2023 | USD 1.26 | -2.07% |
|
Norway |
|
3 |
7.51%
|
Dec. 31, 2023 | USD 2.12 | -1.52% |
|
Norway |
|
4 |
5.74%
|
Dec. 31, 2023 | USD 4.93 | -3.23% |
|
Norway |
|
5 |
-6.10%
|
Dec. 31, 2023 | USD 3.68 | -8.83% |
|
Norway |
|
6 |
-46.66%
|
Dec. 31, 2023 | USD 1.06 | -3.51% |
|
Norway |
|
7 |
-73.65%
|
Dec. 31, 2023 | USD 0.19 | -2.43% |
|
Norway |
The Healthcare company in Norway with the highest Return on Capital Employed (ROCE) is Medistim ASA (Oslo Stock Exchange: MEDI.OL) at 31.95%.
The Healthcare company in Norway with the lowest Return on Capital Employed (ROCE) is Ultimovacs ASA (Oslo Stock Exchange: ULTI.OL) at -73.65%.
The top 10 Healthcare companies in Norway by Return on Capital Employed (ROCE) are Medistim ASA, ArcticZymes Technologies ASA, Navamedic ASA, Photocure ASA, Gentian Diagnostics ASA, Lifecare AS and Ultimovacs ASA.
The bottom 10 Healthcare companies in Norway by Return on Capital Employed (ROCE) are Ultimovacs ASA, Lifecare AS, Gentian Diagnostics ASA, Photocure ASA, Navamedic ASA, ArcticZymes Technologies ASA and Medistim ASA.